Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus monotherapy in advanced transitional cell carcinoma after platinum failure
2008-004575-21Phase 2Terminated
- Sponsor
- Cliniques universitaires Saint-Luc
- Start
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of everolimus in transitional cell carcinoma (TCC), sponsored by Cliniques universitaires Saint-Luc. Primary endpoint: Disease control rate (SD + PR + CR). Started Sep 2008; status: terminated.
02
Drugs
everolimus
03
Conditions
transitional cell carcinoma (TCC)
Beyond the preview
Go deeper on 2008-004575-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004575-21.